Diagnostic modalities and best approach For cholangiocarcinoma, hepatocellular carcinoma, neuroendocrine tumors and colorectal tumors
Subtleties of underlying conditions and comorbidities among patients with hepatocellular carcinoma
Strategies for the use of individual and combination therapies
The full range of treatment options currently available for treating cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
Mechanisms of disease and the relevance to the future development of molecular-tailored diagnostic and treatment modalities for cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
Importance and utility of the multidisciplinary approach to the treatment of cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
How combining treatment options for colorectal tumors can achieve successes that transcend any single modality
New standards for determining the indications and contraindications for surgical intervention of colorectal cancers, cholangiocarcinomas and neuroendocrine tumors
Rationale and success of new, more aggressive treatment strategies for neuroendocrine tumors
Who should Attend
Surgical oncologists, gastroenterologists, surgeons and other healthcare professionals who treat patients with primary or metastatic liver tumors and primary care physicians.
Past Events
Liver Tumors: New Technologies and New Managements 2013 - 08-09 Jun 2013, Cedars-Sinai Medical Center, Los Angeles, California, United States (34847)
Important
Please, check "Liver Tumors: New Technologies and New Managements" official website for possible changes, before making any traveling arrangements
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.